Lee Biosolutions Matt Lee

Thermal Paper Matt
ELE5013 EACH
EUR 27.6

Human IgG antibody Laboratories manufactures the lee biosolutions matt lee reagents distributed by Genprice. The Lee Biosolutions Matt Lee reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Lee Biosolutions Ltd.. Other Lee products are available in stock. Specificity: Lee Category: Biosolutions Group: Matt Lee

True north Cryobox 5mLBlue
PK10
EUR 153.6

True north Cryobox 15mLNatural
PK10
EUR 212.4

True north Cryobox 15mLBlue
PK10
EUR 212.4

True north Cryobox 50mLNatural
PK10
EUR 210

True north Cryobox 50mLBlue
PK10
EUR 210

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

Matt Lee information

LEE011 succinate
B1084-100 100 mg
EUR 420
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-200 200 mg
EUR 640.8
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-5 5 mg
EUR 160.8
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-5.1 10 mM (in 1mL DMSO)
EUR 192
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-50 50 mg
EUR 300
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-500 500 mg
EUR 1101.6
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

Ribociclib (LEE011)
9481-25 each
EUR 548.4

Ribociclib (LEE011)
9481-5 each
EUR 183.6

LEE011 hydrochloride
B1083-10 10 mg
EUR 234
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 hydrochloride
B1083-100 100 mg
EUR 602.4
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 hydrochloride
B1083-5 5 mg
EUR 189.6
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 hydrochloride
B1083-5.1 10 mM (in 1mL DMSO)
EUR 201.6
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 hydrochloride
B1083-50 50 mg
EUR 385.2
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

Recombinant Saccharomyces Cerevisiae LEE1 Protein (aa 1-301) [His]
VAng-Wyb4934-1mg 1 mg
EUR 5289.6
Description: Saccharomyces Cerevisiae (strain ATCC 204508 / S288c) Lee1p protein, recombinant protein.

Decorsin, Leech
5-01032 4 x 1mg Ask for price

[Des-Asp10]Decorsin, Leech
5-00164 4 x 1mg Ask for price

LEEC C100 Classic Incubator 100L
INC1900 EACH
EUR 2649.6